Vaccinating India’s billion against coronavirus: After Pfizer, now Serum Institute seeks indemnity from liability

By: |
June 03, 2021 7:58 PM

"Rules should be the same for everyone," a source at the Serum Institute said.

Serum Institute of India, SII, Adar Poonawalla, Pfizer, AstraZeneca, Oxford, Covishield, coronavirus, covid19Serum Institute is producing Oxford-AstraZeneca's COVID vaccine 'Covishield' in India. (Reuters photo)

Domestic vaccine major Serum Institute of India is seeking indemnity from liability for its COVID vaccines, saying that the rules should be same for all the companies, according to sources. The development comes after requests for indemnity and exemption from bridging trials have been made by Pfizer and Moderna to the Narendra Modi government.

“Rules should be the same for everyone,” a source at the Serum Institute said. Earlier, Serum Institute CEO Adar Poonawalla had said that vaccine manufacturers need to have protection against all lawsuits for their vaccines, especially during a pandemic. In December 2020, speaking at an event, he said, “we need to have the government indemnify manufacturers, especially vaccine manufacturers, against all lawsuits. In fact, COVAX and other countries have already started talking about that”.

Serum Institute is producing Oxford-AstraZeneca’s COVID vaccine ‘Covishield’ in India and clinical trials of its second vaccine ‘Covovax’ have begun in the country and the company hopes to launch it by September this year.


Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1Four passengers from UK, Netherlands test positive for Covid, samples sent for genome sequencing
2Covid infection linked with increased complications in pregnancy, birth: Study
3NASA delays astronaut spacewalk indefinitely as it receives notification of potentially dangerous debris